About
Axor Biosystems was founded to improve biological reaction purification and QC processes by 100x - to help accelerate breakthroughs in diagnoses and treatment of cancer, dementia, senescence, genetic diseases …
Embedded Files
Motivation
Motivation
AI has transformed biology.
We can now analyze biological data faster than ever before.
But in doing so, we've created a new bottleneck: generating and preparing enough high-quality biological sample reactions.
Today, biology isn't limited by computation—it is limited by a laboratory infrastructure that hasn't fundamentally changed in decades.
The complex workflows, high overhead costs and inefficiencies of traditional reaction preparation are contributing to a worsening bottleneck - a barrier choking data generation and decreasing the flow of scientific breakthroughs.
We decided to focus on this challenge with pie-in-the-sky product requirements:
A single system, eliminating the multiple instruments and protocols. A single system to perform the required biochemical reaction, separation, quantitation, and molecular weight analysis.
A single consumable, replacing the large number and volumes of reagents, cartridges, beads, tips, troughs, plates, tubes.
At least 10x faster than the current methods
At least 10x cheaper
We stumbled upon an elegantly simple solution. Embedding the reaction, purification and QC processes within the construct of a laboratory microplate. And we could achieve a 100x improvement!
Founding team
Founding team
Brett Anderson, the CTO, and Abizar Lakdawalla, the CEO, worked together at Apton Biosystems to develop an ultra-high throughput Next Generation Sequencing & Proteomics platform based on a novel sub-diffraction imaging technology invented by Bryan Staker, co-founder and CTO of Apton.
The co-founders have >25 years of experience in developing, building and launching systems & applications in genomics at Apton Biosystems, IDbyDNA, Proxeom, Resilience, Synthego, Ultima Genomics, Illumina and Thermo Fisher Scientific.
Brett Anderson, PhD
Brett Anderson, PhD
CTO
Brett is a single-molecule bioengineer by training with a strong background in developing firmware and software for complex life sciences tools, from single-molecule nanopore sequencing to brain implant monitors.
He likes integrating real-time imaging to steer biomolecules through meandering channels under the influence of hard-to-resist electrical currents.
Abizar Lakdawalla, PhD
Abizar Lakdawalla, PhD
CEO
Abizar had worked on microfluidic devices for Sanger sequencing before helping develop and launch Next Generation sequencing platforms and assays.
He likes conjuring up solutions to challenging problems while tacking in a 20 knot wind.
Axor is supported by advisors with incredible expertise in the life science tools industry and in high-density electronics technolgies who held senior positions (GM's or VP's) with our potential acquisitors.
Kevin Corcoran
ex-GM: Life Tech, Agilent
Martin Doyle
VP, Business Development: Life Tech, Agilent, Quantapore
Jim Cooke
VP, Electronics: Micron Tech, Toshiba
Page updated
Report abuse